RGT-691

N/A

Report date: 2024/02/22 11:57:34
NME

Base Information

Drug NameRGT-691
Drug Alias NameRGT-691
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-arginine deiminase type-4 inhibitors
TargetsProtein-arginine deiminase type-4
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRegor Therapeutics Group
China Registration ClassN/A

Develop Information

Active CompaniesRegor Therapeutics Group
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A